Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2025-05-29 Board/Management Inform…
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
zal10_Oswiadczenie_Zbigniew_Molenda.pdf
Board/Management Information Classification · 98% confidence The document is a formal declaration ('Oświadczenie') by an individual, Zbigniew Molenda, consenting to be nominated and serve as a member of the Supervisory Board ('Rada Nadzorcza') of PHARMENA S.A. It includes mandatory compliance checks regarding independence criteria, legal capacity, criminal record, and conflicts of interest, referencing Polish corporate law and EU recommendations. This type of document directly relates to the composition and qualifications of the company's governing body (Board/Management). Therefore, it best fits the Board/Management Information category (MANG). It is not an earnings release (ER), a full annual report (10-K), or a proxy statement (PSI), but a specific declaration required for board appointments.
2025-05-29 Polish
zal06_250529_Informacja_dot_Zbigniewa_Molenda.pdf
Board/Management Information Classification · 98% confidence The document is titled 'Informacje dotyczące Pana Zbigniewa Molenda - członka Rady Nadzorczej...' and details the appointment of an individual to the Supervisory Board ('Członek Rady Nadzorczej'). It explicitly references a Polish regulation ('Rozporządzenia Ministra Finansów z dnia 29 marca 2018 roku w sprawie informacji bieżących i okresowych przekazywanych przez emitentów papierów wartościowych'). This type of filing, announcing changes in the board of directors or senior management, directly corresponds to the Management/Board Information category. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It is a specific disclosure about a board member's appointment and background.
2025-05-29 Polish
zal05_Oswiadczenie_Tomasz_Filipiak.pdf
Board/Management Information Classification · 98% confidence The document is a formal declaration ('Oświadczenie') by an individual, Tomasz Filipiak, consenting to be nominated and serve as a member of the Supervisory Board ('Rada Nadzorcza') of PHARMENA S.A. It includes detailed compliance checks regarding independence criteria, legal standing, and conflicts of interest, which are standard requirements for board appointments. This content directly relates to the composition and governance structure of the company's board. This aligns best with the 'Board/Management Information' category, which covers announcements of changes in the board of directors or senior management, as this document confirms a new board member's acceptance of the role. It is not an earnings release, annual report, or a general regulatory filing.
2025-05-29 Polish
zal04_250529_Informacja_dot_Tomasz_Filipiak..pdf
Board/Management Information Classification · 98% confidence The document provides detailed information regarding a specific individual, Tomasz Filipiak, who is a member of the Supervisory Board ('Przewodniczący Rady Nadzorczej'). It lists his appointment date, function, education, professional history, and other business activities. This structure strongly aligns with disclosures required when there is a change or update concerning a member of the board of directors or senior management. This matches the definition for Board/Management Information (MANG). The reference to Polish regulation (§ 10 Rozporządzenia Ministra Finansów) confirms it is a formal corporate disclosure related to governance personnel.
2025-05-29 Polish
zal08_Oswiadczenie_Jacek_Dauenhauer.pdf
Board/Management Information Classification · 98% confidence The document is a formal declaration ('Oświadczenie') by an individual, Jacek Dauenhauer, consenting to be nominated and serve as a member of the Supervisory Board ('Rada Nadzorcza') of PHARMENA S.A. It includes mandatory compliance checks regarding independence criteria, legal restrictions, and conflicts of interest, which are standard requirements for board appointments in Polish listed companies. This type of document directly relates to the composition and governance structure of the company's leadership, specifically the board of directors/supervisors. This aligns best with the 'Board/Management Information' category (MANG), which covers announcements of changes in the board of directors or senior management.
2025-05-29 Polish
zal01_250529_Informacja_dot_Jacka_Dauenhauera.pdf
Board/Management Information Classification · 98% confidence The document is a formal disclosure in Polish regarding a specific individual, Jacek Dauenhauer, detailing his appointment date (April 3, 2024), his role (Członek Rady Nadzorczej - Member of the Supervisory Board), his professional background, and other directorships he holds. This structure, referencing specific regulatory requirements (like § 10 of the Minister of Finance Regulation) for reporting changes in management or supervisory bodies, strongly indicates a disclosure about board or management composition/changes. This aligns directly with the definition for Board/Management Information (MANG). It is not an earnings release (ER), an annual report (10-K), or a director's dealing report (DIRS), as it focuses on appointment and qualifications, not transactions.
2025-05-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.